We present a case of a 57-year-old woman who underwent gamma-knife radiosurgery (GKRS) for pontine metastasis. Magnetic resonance (MR) imaging 2.8 months after GKRS showed T 2 hyperintensity and hypertrophy of the left inferior olivary nucleus (ION) without gadolinium enhancement and smaller pontine metastasis. We diagnosed the signal change in the left ION as hypertrophic olivary degeneration (HOD) resulting from damage to the left central tegmental tract. We believe this is theˆrst report to describe HOD after GKRS for pontine metastasis.
Introduction
Hypertrophic olivary degeneration (HOD) is a unique transsynaptic degeneration caused by lesions in the Guillain-Mollaret triangle, which comprises the dentate-rubro-thalamic, central tegmental, and olivocerebellar tracts. 1 On magnetic resonance (MR) imaging, HOD can be seen as enlargement of the inferior olivary nucleus (ION) with T 2 prolongation. 2, 3 We present a case of HOD after gamma-knife radiosurgery (GKRS) for pontine metastasis. Although HOD is a well known phenomenon after cerebrovascular diseases, such as hemorrhage or infarction involving the Guillain-Mollaret triangle, little is known about HOD occurring after GKRS for brain tumors.
Case Report
A 57-year-old woman underwent MR imaging of the brain one month after presenting with symptoms of walking disturbance and dysarthria. She had a history of surgery for right breast tumor 19 months earlier and postoperative adjuvant chemotherapy. The pathological diagnosis of the excised breast tumor was invasive ductal carcinoma, scirrhous type. On initial MR imaging, T 2 -weighted imaging showed hyperintense, well circumscribed tumors on the left side of the pontine tegmentum and subcortical region of the right inferior temporal gyrus (Fig. 1A) . Mild peritumoral edema was evident in each tumor. No abnormal intensity was found in the medulla oblongata on the initial T 2 -weighted image (Fig. 1B) . These tumors showed uniform enhancement, and no abnormal contrast enhancement was observed in the medulla oblongata on gadolinium (Gd)-enhanced T 1 -weighted image (Fig. 1C) . We diagnosed the tumors in the pontine tegmentum and left temporal lobe as metastases from the breast cancer. GKRS was subsequently performed for each tumor. The central dose for the pontine metastasis was 34.2 Gy, and the marginal dose was 18 Gy. T 2 -weighted images acquired 1.4 months after GKRS showed reductions in tumor size and peritumoral edema for each metastasis ( Fig. 2A ) and increased T 2 signal intensity in the left ION (Fig. 2B) . Although contrast enhancement in these residual tumors was apparent on Gd-enhanced T 1 -weighted image, no contrast enhancement was seen in the left ION. In images obtained 2.8 months after GKRS, the metastases displayed further decreases in size, and enlargement of the left ION with high intensity was found on T 2 -weighted image ( Fig. 3A-C) . Gd-enhanced Y. Shinohara et al.
Magnetic Resonance in Medical Sciences
T 1 -weighted images showed no contrast enhancement in the enlarged left ION (Fig. 3D) . T 2 -weighted images 5 months after GKRS showed enlargement of the left ION with high intensity. Enlargement of the left ION was decreased at 18 and 29 months after GKRS on T 2 -weighted images, but the 
Discussion
HOD is a pathological phenomenon that occurs after injury to the Guillain-Mollaret triangle, primarily as a result of hemorrhage or infarction. 1 Several authors 2,3 have reported typical MR imagingˆndings of HOD and its temporal evolution; T 2 prolongation in the ION occurs about 3 weeks after cerebrovascular disease aŠecting the Guillain-Mollaret triangle. Hypertrophic ION with T 2 prolongation appears about 5 months later, and MR imaging after a few years demonstrates atrophic ION. 2, 3 These MR imagingˆndings appear to correlate with the pathologic descriptions by Goto's group. 4 The initial MR imaging change of T 2 prolongation at the ION may relate to an initial phase of neuronal hypertrophy, in which gliosis and increased water content are associated with demyelination and vacuolization. ION hypertrophy is likely the result of neuronal and astrocytic hypertrophic precursors to cell death. Finally, the ION undergoes atrophy. Clinical presentations associated with HOD include palatal tremor and ocular myoclonus. [1] [2] [3] [4] [5] [6] [7] However, the incidence of these symptoms varies. 2, 5, 8 Some reports describe HOD occurring after surgical resection of a brain tumor, [5] [6] [7] but HOD is rarely caused simply by a tumor in the GuillainMollaret triangle. 8, 9 We believe this case report represents theˆrst published description of HOD following GKRS for a brain tumor.
GKRS is a stereotactic radiotherapy that targets only the position in the tumor bed where the radiologist or neurosurgeon directs the high dose, single-fraction irradiation, thereby avoiding radiation of healthy tissue. GKRS is available for various neurological diseases, such as arteriovenous malformations, acoustic neurinomas, meningiomas, and metastatic brain tumors. A few reports have shown histopathological changes at the site of irradiation following GKRS. 10, 11 Hirato and colleagues 11 reported destructive changes, such as the disappearance of viable cells, coagulation necrosis, andˆbrinoid degeneration of the vascular wall in the center of the target of GKRS. It is di‹cult to clarify whether MR imagingˆndings in our case indicate such histopathological changes. However, we suppose that invadedˆbers within the left central tegmental tract had su‹cient destructive histopathological damage by GKRS to cause secondary degeneration in the left ION. Though there are few reports of HOD presenting as enlargement of the ION at MR imaging within 4 months after onset in patients with cerebrovascular disease, [2] [3] [4] we observed ION enlargement with T 2 prolongation 2.8 months after GKRS for pontine metastasis in our patient. We speculate that secondary degeneration of the ION after GKRS for brain tumor occurs more rapidly than secondary degeneration of the ION after cerebrovascular disease because of the diŠerence in the degree and extent of histological damage involving the Guillain-Mollaret triangle.
In cases showing changes in ION signal after GKRS for tumors within the Guillain-Mollaret triangle, it is crucial that the neuroradiologist does not interpret such changes as tumor recurrence. In addition to the location of the irradiatedˆeld, a signiˆcant clue to diagnosis will be a lack of contrast enhancement within the enlarged ION. 12 Because many kinds of malignant brain tumors demonstrate good contrast enhancement, Gd-enhanced T 1 -weighted imaging may be useful for distinguishing recurrent tumors from HOD.
In conclusion, damage involving the GuillainMollaret triangle after GKRS for brain tumors can cause ION enlargement with T 2 prolongation. Thiŝ nding on MR imaging represents HOD and should be distinguished from tumor recurrence.
